Physician profile
Lee Thornton
NPI 1043318280
$14,222.09
in general payments reported to CMS, 2019-2025
12 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $910 · 2020: $121 · 2021: $228 · 2022: $204 · 2023: $649 · 2024: $12K · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $11K · Food and Beverage: $787 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $11,200.00 |
| Food and Beverage | $787.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $772.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $11,369.78 | 2023-2024 | |
| Abbvie INC. | $1,234.52 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Sientra, INC. | $755.59 | 2019-2021 | |
| Allergan, INC. | $496.31 | 2019-2022 | |
| Organogenesis INC. | $102.69 | 2021-2024 | Puraply |
| Triad Life Sciences INC. | $69.19 | 2022 | |
| Galderma Laboratories, L.P. | $46.04 | 2021-2025 | Dysport |
| Dusa Pharmaceuticals, INC. | $45.43 | 2019 | |
| Integra Lifesciences Corporation | $43.11 | 2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Pacira Pharmaceuticals Incorporated | $24.38 | 2024 | Exparel |
| Becton, Dickinson and Company | $18.40 | 2024 | |
| Novo Nordisk INC | $16.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.